deltatrials
Completed NA INTERVENTIONAL 1-arm NCT05145257

Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms

Sponsor: Citruslabs

Interventions Elix Cycle Balance
Updated 6 times since 2022 Last updated: Dec 10, 2024 Started: Jan 5, 2022 Primary completion: May 31, 2022 Completion: May 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05145257, this NA trial focuses on Menstrual Pain and PMS and remains completed. Sponsored by Citruslabs, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Jul 2022 · 4 months · monthly snapshot~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotCompleted~Feb 2025 – present · 17 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Feb 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Feb 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jul 2022 — Jul 2024 [monthly]

    Completed NA

    Status: RecruitingCompleted

  5. Mar 2022 — Jul 2022 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

Show 1 earlier version
  1. Jan 2022 — Mar 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Citruslabs
  • Zenchi, Inc.
Data source: Zenchi, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations